Adequate Engraftment with Lower Hematopoietic Stem Cell Dose
Data for 108 patients with multiple myeloma and lymphoma who received a stem cell dose less than 2 x 106/kg with those who received higher dose was compared.Neutrophil engraftment, platelet engraftment, length of hospital stay and incidence of proven bacterial infections were similar in both groups. ASCT can be safely performed even with lower HSC dose in non-cryopreserved setting.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Preethi Jeyaraman, Pronamee Borah, Nitin Dayal, Sangeeta Pathak, Rahul Naithani Tags: Original Study Source Type: research
More News: Hematology | Hospitals | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study